CBUS CIK: 1705843

Cibus, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY22
millions USD
FY21:
−2.57
FY22:
0.16
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.3
FY22:
−22.4
FY23:
−319
FY24:
−258
FY25:
−97.5
(positive)
Change from FY21 to FY22
millions USD
FY21:
−27.0
FY22:
−15.3
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.2
FY22:
−16.9
FY23:
−338
FY24:
−283
FY25:
−132
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.2
FY22:
−16.9
FY23:
−268
FY24:
−251
FY25:
−127

All amounts in millions USD Data sources:SEC EDGARTwelve Data